HERON THERAPEUTICS, INC. /DE/ Balance Sheet
HRTX|2 years of annual SEC 10-K data (FY2016-FY2017)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
HERON THERAPEUTICS, INC. /DE/ had $234M in total assets and $118M in shareholders' equity as of FY2017.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 |
|---|---|---|
| Cash & Equivalents | $75.2M | $72.7M |
| Accounts Receivable | $41.9M | $2.0M |
| Inventory | $10.1M | $5.3M |
| Current Assets | $228.1M | $62.1M |
| PP&E (Net) | $6.0M | $5.1M |
| Total Assets | $234.3M | $67.5M |
| Current Liabilities | $103.2M | $38.7M |
| Shareholders' Equity | $118.1M | $63.1M |